| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 |
| Total Revenue | 762 | 664 | 625 |
| Cost of Revenue | 134 | 135 | 170 |
|
| Gross Profit |
-
| 529 | 455 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 680 | 656 | 608 |
| Non Recurring |
-
|
-
|
-
|
| Others | 33 |
-
| 15 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss |
-
| (127) | (168) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (85) | (127) | (168) |
| Interest Expense |
-
|
-
|
-
|
| Income Before Tax | (85) | (127) | (168) |
| Income Tax Expense | (29) | (44) | (56) |
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (56) | (83) | (112) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (56) | (83) | (112) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($56) | ($83) | ($112) |
0.01% Nasdaq 0.00%
Income Statement
